July 12, 2019 / 8:29 PM / 9 days ago

Eton Pharma's conjunctivitis treatment fails to win FDA approval

July 12 (Reuters) - The U.S. Food and Drug Administration declined to approve Eton Pharmaceuticals Inc’s treatment for conjunctivitis, the drug developer said on Friday.

No concerns were raised about the clinical data in the application, and the company expects to respond to the letter shortly, Eton said. (Reporting by Aakash Jagadeesh Babu in Bengaluru; Editing by Anil D’Silva)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below